Atlas Trials

Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy

Clinical trial NCT03242265 · TERMINATED

Trial details

NCT number
NCT03242265
Sponsor
ATGen Canada Inc
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Immunity, InnateProstatic Neoplasm
Start date
2017-04-04
Primary completion
2019-03-20
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.